There is growing interest in the effects of pharmaceuticals in the environment. However, the focus when assessing the risk of pharmaceuticals in the environment is done in the pre-authorisation phase, and there is no standard approach to identify, report and collect suspected adverse events related to environmental exposure and impact. This study aims to describe the reporting of environment-related terms to VigiBase, the WHO...